<< Full experiment listing


DataSet Summary

  • HostingRepository: PRIDE
  • AnnounceDate: 2018-09-13
  • AnnouncementXML: Submission_2018-09-13_11:28:16.xml
  • DigitalObjectIdentifier:
  • ReviewLevel: Peer-reviewed dataset
  • DatasetOrigin: Original data
  • RepositorySupport: Unsupported dataset by repository
  • PrimarySubmitter: Sharon Pitteri
  • Title: Quantitative proteomic profiling reveals key pathways in the anti-cancer action of methoxychalcone derivatives in triple negative breast cancer
  • Description: Synthetic analogues of chalcones were investigated as potential therapeutics for triple negative breast cancer. These analogues were used in quantitative proteomic experiments to determine the mechanism of action.
  • SpeciesList: scientific name: Homo sapiens (Human); NCBI TaxID: 9606;
  • ModificationList: TMT6plex-126 reporter+balance reagent acylated residue; monohydroxylated residue; iodoacetamide derivatized residue
  • Instrument: LTQ Orbitrap Elite

Dataset History

VersionDatetimeStatusChangeLog Entry
02018-04-20 01:34:25ID requested
12018-09-13 11:28:17announced

Publication List

  1. Going CC, Tailor D, Kumar V, Birk AM, Pandrala M, Rice MA, Stoyanova T, Malhotra S, Pitteri SJ, Quantitative Proteomic Profiling Reveals Key Pathways in the Anticancer Action of Methoxychalcone Derivatives in Triple Negative Breast Cancer. J Proteome Res, 17(10):3574-3585(2018) [pubmed]

Keyword List

  1. submitter keyword: human, cell lines, cancer, drugs, breast cancer

Contact List

    Sharon Pitteri
    • contact affiliation: Canary Center at Stanford For Cancer Early Detection Department of Radiology School of Medicine Stanford University
    • contact email: spitteri@stanford.edu
    • lab head:
    Sharon Pitteri
    • contact affiliation: Stanford University
    • contact email: spitteri@stanford.edu
    • dataset submitter:

Full Dataset Link List

  1. Dataset FTP location
  2. PRIDE project URI
Repository Record List
Subscribe to receive all new ProteomeXchange announcements!
If you have a question or comment about ProteomeXchange, please contact us!